Increased serum concentration of angiogenic factors in malignant melanoma patients correlates with tumor progression and survival.
Abstract
To determine the predictive value of the angiogenic serum factors angiogenin, vascular endothelial growth factor (VEGF), basic fibroblast growth factor (bFGF), and interleukin-8 (IL-8) for the prognosis of patients with malignant melanoma.